DNA methylation age of human tissues and cell types
By Steve Horvath. Genome Biology, 2013
6,226 citations recorded by the source corpus.
It is not yet known whether DNA methylation levels can be used to accurately predict age across a broad spectrum of human tissues and cell types, nor whether the resulting age prediction is a biologically meaningful measure. I developed a multi-tissue predictor of age that allows one to estimate the DNA methylation age of most tissues and cell types. The predictor, which is freely available, was developed using 8,000 samples from 82 Illumina DNA methylation array datasets, encompassing 51 healthy tissues and cell types. I found that DNA methylation age has the following properties: first, it is close to zero for embryonic and induced pluripotent stem cells; second, it correlates with cell passage number; third, it gives rise to a highly heritable measure of age acceleration; and, fourth, it is applicable to chimpanzee tissues. Analysis of 6,000 cancer samples from 32 datasets showed that all of the considered 20 cancer types exhibit significant age acceleration, with an average of 36 years. Low age-acceleration of cancer tissue is associated with a high number of somatic mutations and TP53 mutations, while mutations in steroid receptors greatly accelerate DNA methylation age in breast cancer. Finally, I characterize the 353 CpG sites that together form an aging clock in terms of chromatin states and tissue variance. I propose that DNA methylation age measures the cumulative effect of an epigenetic maintenance system. This novel epigenetic clock can be used to address a host of questions in developmental biology, cancer and aging research.
Subfields: Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/b7ad028fbe0b464636066e95bcef3c1478de5398
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Jason Ernst
- Manolis Kellis
- Daniel W Belsky
- D. Kwon
- Andrew E. Jaffe
- Stephan Beck
- T. Wyss‐Coray
- Andrew E. Teschendorff
In Physiology
- Manolis Kellis
- Jason Ernst
- T. Wyss‐Coray
- Michael S. Kobor
- Meaghan J. Jones
- S. Goodman
- J. Rutledge
- H. Oh
Citations in the corpus
- DNA methylation GrimAge strongly predicts lifespan and healthspan (2019, methodology): “DNAm-based age (epigenetic age) estimators, include the pan tissue epigenetic clock by Horvath 2013 [1], based on 353 CpGs, and an estimator developed by Hannum 2013 [2], based on 71 CpGs in leukocytes.”
- Biological Age Predictors (2017, background): “9 years, respectively) in their corresponding validation cohorts (Hannum et al., 2013; Horvath, 2013).”
- An epigenetic biomarker of aging for lifespan and healthspan (2018, methodology): “The blood-based algorithm by Hannum[10] and the multi-tissue algorithm by Horvath[14] produce age estimates (DNAm age) that correlate with chronological age well above r=0.90 for full age range samples.”
- Measuring biological aging in humans: A quest (2019, background): “Their discovery has been confirmed by many studies across tissues, individuals, and populations, in addition to examining gestational age, and in longitudinal analyses (Horvath, 2013; Knight et al., 2016; Maierhofer et al., 2017; Quach et al., 2017; Sehl, Henry, Storniolo, Ganz, & Horvath, 2017).”
- The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates (2018, methodology): “Of all the different clocks, three have been tested thoroughly as possible markers of biological age: the one developed by Horvath (230), the one by Hannum et al.”
- DNA methylation-based measures of biological age: meta-analysis predicting time to death (2016, methodology): “First, we used the approach by Horvath (2013) based on 353 CpGs, as described in [3] and Methods.”
- DNA methylation and healthy human aging (2015, methodology): “When tracked in a large population, the distribution of DNA methylation levels suggests that these sites change rapidly with age until adulthood, at which point the rate of change slows considerably (Horvath, 2013; Lister et al., 2013).”
- Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020, background): “DNA methylation is associated with development and aging, and can be used as an epigenetic clock to predict the age of various cell and tissue types [510].”
- A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking (2021, methodology): “The widely used Horvath1 multi-tissue clock 14 showed a median deviation of 1.8 years between replicates, and a maximum of 4.8 years.”